Mercer Global Advisors Inc Ironwood Pharmaceuticals Inc Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 15,316 shares of IRWD stock, worth $68,156. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,316

Previous 16,603 7.75%

Holding current value

$68,156

Previous $108,000 42.59%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.93 - $7.04 $5,057 - $9,060	-1,287 Reduced 7.75%	15,316 $62,000
Q2 2024 Aug 12, 2024	SELL	$5.58 - $8.61 $1.23 Million - $1.89 Million	-219,620 Reduced 92.97%	16,603 $108,000
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $35,035 - $65,059	-4,211 Reduced 1.75%	236,223 $2.06 Million
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $37,928 - $49,665	-4,315 Reduced 1.76%	240,434 $2.75 Million
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $286,580 - $394,264	34,737 Added 16.54%	244,749 $2.36 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $208,161 - $239,076	20,610 Added 10.88%	210,012 $2.23 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $107,495 - $130,196	10,366 Added 5.79%	189,402 $1.99 Million
Q4 2022 Feb 08, 2023	BUY	$9.9 - $12.43 $18,869 - $23,691	1,906 Added 1.08%	179,036 $2.22 Million
Q3 2022 Nov 15, 2022	BUY	$10.14 - $12.38 $16,822 - $20,538	1,659 Added 0.95%	177,130 $1.84 Million
Q2 2022 Aug 10, 2022	BUY	$11.05 - $12.72 $214,613 - $247,047	19,422 Added 12.45%	175,471 $2.02 Million
Q1 2022 May 10, 2022	BUY	$10.61 - $12.88 $333,493 - $404,844	31,432 Added 25.22%	156,049 $1.96 Million
Q4 2021 Feb 04, 2022	BUY	$10.86 - $13.95 $685,266 - $880,245	63,100 Added 102.57%	124,617 $1.45 Million
Q3 2021 Nov 10, 2021	BUY	$11.92 - $13.92 $155,901 - $182,059	13,079 Added 27.0%	61,517 $803,000
Q2 2021 Aug 10, 2021	BUY	$10.16 - $13.11 $25,908 - $33,430	2,550 Added 5.56%	48,438 $623,000
Q1 2021 May 11, 2021	SELL	$9.04 - $11.86 $14,048 - $18,430	-1,554 Reduced 3.28%	45,888 $513,000
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $94,129 - $126,892	10,401 Added 28.08%	47,442 $540,000
Q3 2020 Dec 10, 2020	BUY	$8.99 - $10.74 $13,341 - $15,938	1,484 Added 4.17%	37,041 $333,000
Q2 2020 Aug 10, 2020	BUY	$9.14 - $11.97 $324,990 - $425,617	35,557 New	35,557 $367,000

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Ironwood Pharmaceuticals Inc Transaction History